Authors: MOHR P MAKKI A BREITBART E SCHADENDORF D

Citation: P. Mohr et al., COMBINED TREATMENT OF STAGE-IV MELANOMA PATIENTS WITH AMIFOSTINE AND FOTEMUSTINE - A PILOT-STUDY, Melanoma research, 8(2), 1998, pp. 166-169

Authors: SCHADENDORF D SUN Y MOLLER H MAKKI A DORBIC T WITTIG B HENZ BM MOLLER P

Citation: D. Schadendorf et al., IL-7-GENE-TRANSFER INTO AUTOLOGOUS MELANOMA-CELLS FOR VACCINATION - APILOT-STUDY IN PATIENTS WITH ADVANCED MELANOMA, Journal of investigative dermatology, 107(3), 1996, pp. 40-40

Authors: KERN MA ARTUC M HELMBACH H KARMANN D MAKKI A SCHADENDORF D

Citation: Ma. Kern et al., ANALYSIS OF DRUG-RESISTANCE OF MELANOMA-CELLS - PHARMACOLOGICAL CHARACTERIZATION, CROSS-RESISTANCE AND GENETIC-REGULATION, Journal of investigative dermatology, 107(3), 1996, pp. 43-43

Authors: SCHADENDORF D KERN MA ARTUC M PAHL HL ROSENBACH T FICHTNER I NURNBERG W STUTING S VONSTEBUT E WORM M MAKKI A JURGOVSKY K KOLDE G HENZ BM

Citation: D. Schadendorf et al., TREATMENT OF MELANOMA-CELLS WITH THE SYNTHETIC RETINOID CD437 INDUCESAPOPTOSIS VIA ACTIVATION OF AP-1 IN-VITRO, AND CAUSES GROWTH-INHIBITION IN XENOGRAFTS IN-VIVO, The Journal of cell biology, 135(6), 1996, pp. 1889-1898

Authors: SCHADENDORF D FICHTNER I MAKKI A ALIJAGIC S KUPPER M MROWIETZ U HENZ BM

Citation: D. Schadendorf et al., METASTATIC POTENTIAL OF HUMAN-MELANOMA CELLS IN NUDE-MICE - CHARACTERIZATION OF PHENOTYPE, CYTOKINE SECRETION AND TUMOR-ASSOCIATED ANTIGENS, British Journal of Cancer, 74(2), 1996, pp. 194-199

Authors: SCHADENDORF D MAKKI A STAHR C VANDYCK A WANNER R SCHEFFER GL FLENS MJ SCHEPER R HENZ BM

Citation: D. Schadendorf et al., MEMBRANE-TRANSPORT PROTEINS ASSOCIATED WITH DRUG-RESISTANCE EXPRESSEDIN HUMAN-MELANOMA, The American journal of pathology, 147(6), 1995, pp. 1545-1552